Koskiniemi M, Pettay O, Raivio M, Sarna S
Acta Paediatr Scand. 1978 Jan;67(1):17-24. doi: 10.1111/j.1651-2227.1978.tb16271.x.
131 patients suffering from meningitis due to Haemophilus influenzae or parainfluenzae were re-examined after 1-15 years, using hospital records, questionnaires, and audiological examination, especially to compare chloramphenicol and ampicillin therapy. Mortality was 3.8%. Subdural effusions occurred in 14.5% of cases uni- or bilaterally. There was deafness in 2.3%, and moderate hearing loss in 8.4%. Convulsions appeared later in 6.9%. The final outcome was good in 60%. The most important factors in prognosis seemed to be the severity of the symptoms and the condition of the patient on admission to hospital. No clear difference was seen between the results of chloramphenicol and ampicillin therapy, but total loss of vestibular function was found in 3 cases in the ampicillin group, and in none in the chloramphenicol group. In mortality and deafness, the differences in outcome were similar, although not statistically significant. As these observations show, the therapy used in Haemophilus influenzae meningitis needs re-evaluation.
对131例因流感嗜血杆菌或副流感嗜血杆菌引起脑膜炎的患者,在1至15年后进行了复查,采用医院记录、问卷调查和听力检查,尤其对氯霉素和氨苄西林治疗进行比较。死亡率为3.8%。14.5%的病例出现单侧或双侧硬膜下积液。2.3%的患者出现耳聋,8.4%的患者有中度听力损失。6.9%的患者后期出现惊厥。60%的患者最终预后良好。预后的最重要因素似乎是症状的严重程度和入院时患者的状况。氯霉素和氨苄西林治疗结果未见明显差异,但氨苄西林组有3例出现前庭功能完全丧失,而氯霉素组无此情况。在死亡率和耳聋方面,结果差异相似,虽无统计学意义。正如这些观察结果所示,流感嗜血杆菌脑膜炎的治疗方法需要重新评估。